======= COMMD2 =======
== Gene Information ==
* **Official Symbol**: COMMD2
* **Official Name**: COMM domain containing 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51122|51122]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86X83|Q86X83]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=COMMD2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20COMMD2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616699|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). {ECO:0000269|PubMed:15799966, ECO:0000305|PubMed:21778237}.
|HCaRG|
No GO term information is available for this gene.
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.47|
|[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.4|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.36|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.22|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.03|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.89|
|[[:results:exp85|UM0129480 7μM R02 exp85]]|-1.89|
|[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.75|
|[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.71|
^Gene^Correlation^
|[[:human genes:c:commd5|COMMD5]]|0.594|
|[[:human genes:v:vps29|VPS29]]|0.518|
|[[:human genes:a:arpc2|ARPC2]]|0.518|
|[[:human genes:c:commd7|COMMD7]]|0.515|
|[[:human genes:c:commd3|COMMD3]]|0.51|
|[[:human genes:c:commd9|COMMD9]]|0.503|
|[[:human genes:a:arpc4|ARPC4]]|0.482|
|[[:human genes:a:actr3|ACTR3]]|0.479|
|[[:human genes:c:commd10|COMMD10]]|0.474|
|[[:human genes:c:ccdc22|CCDC22]]|0.472|
|[[:human genes:c:commd8|COMMD8]]|0.464|
|[[:human genes:l:lzic|LZIC]]|0.452|
|[[:human genes:k:kiaa0196|KIAA0196]]|0.436|
|[[:human genes:k:kiaa1033|KIAA1033]]|0.422|
|[[:human genes:c:ccdc53|CCDC53]]|0.421|
|[[:human genes:a:acsl4|ACSL4]]|0.412|
|[[:human genes:c:c16orf62|C16orf62]]|0.409|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10111
* **Expression level (log2 read counts)**: 5.65
{{:chemogenomics:nalm6 dist.png?nolink |}}